CORALABPharmaceuticals
Coral Laboratories Ltd — PE Ratio & Valuation Analysis
₹370.55
-4.99%
Current P/E9.95xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E17.3x42.5% below avg
✅
68.7% Discount to Industry
CORALAB P/E 9.95x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹44.19 | ₹763 | 17.3x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Coral Laboratories Ltd Valuation
Coral Laboratories Ltd (CORALAB) currently trades at 9.95x earnings. The Pharmaceuticals sector average PE is 31.77x. CORALAB is trading at a discount to peers — may indicate relative value. Historically, CORALAB has traded at an average PE of 17.3x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
13.06%
Dividend Yield
0.30%
More on Coral Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.